This study is in progress, not accepting new patients
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Los Angeles 5368361, California 5332921 and other locations
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- BeiGene
- ID
- NCT04277637
- Phase
- Phase 1 Mature B-Cell Malignancies Research Study
- Study Type
- Interventional
- Participants
- About 437 people participating
- Last Updated